Research

lungs
August 9, 2012

New therapeutic target for cold, flu viruses identified

Viruses that cause acute respiratory infections — such as human metapneumovirus (HMPV) and flu — impair a set of immune system cells that should clear the virus from the lungs.
Now, Vanderbilt University investigators have discovered the signaling pathway that disables these immune cells.

By Leigh MacMillan
July 17, 2012

Insights for neuroscience drug discovery

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects.

By Leigh MacMillan
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

By Bill Snyder
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

By VUMC News and Communications
May 10, 2012

Probing epilepsy’s molecular sparks

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.

By Leigh MacMillan
May 2, 2012

Early stomach troubles augur anxiety

Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.

By VUMC News and Communications
April 6, 2012

Plant compound quells inflammation

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.
By Leigh MacMillan
March 16, 2012

Colon cancer’s cellular crossroads

New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.
By VUMC News and Communications
January 26, 2012

Investigators seek clues to resistance to melanoma drug

Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.
By VUMC News and Communications
December 1, 2011

Pathway to colon cancer progression

Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis.
By VUMC News and Communications
November 11, 2011

Averting a future oncologist shortage

Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists.
By Leigh MacMillan
October 7, 2011

Heart protein may be target for colon cancer therapies

A protein critical in heart development may also play a part in colon cancer progression.
By VUMC News and Communications
July 20, 2011

Vanderbilt study links military service in Middle East with serious lung disorder

A Vanderbilt study of U.S. soldiers returning from the wars in Iraq and Afghanistan shows a serious lung condition linked to prolonged exposures to sulfur fires and burn pits.
By Craig Boerner
1 … 114 115 116 117 118 … 126